DE69400692T2 - Substituierte Piperazine, ihre Verfahrensherstellung und die enthaltenen pharmazeutischen Zusammenfassungen - Google Patents

Substituierte Piperazine, ihre Verfahrensherstellung und die enthaltenen pharmazeutischen Zusammenfassungen

Info

Publication number
DE69400692T2
DE69400692T2 DE69400692T DE69400692T DE69400692T2 DE 69400692 T2 DE69400692 T2 DE 69400692T2 DE 69400692 T DE69400692 T DE 69400692T DE 69400692 T DE69400692 T DE 69400692T DE 69400692 T2 DE69400692 T2 DE 69400692T2
Authority
DE
Germany
Prior art keywords
summaries
pharmaceutical
contain
process manufacture
substituted piperazines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69400692T
Other languages
English (en)
Other versions
DE69400692D1 (de
Inventor
Jean-Jacques Godfroid
Aazdine Lamouri
Estera Touboul
Xuan Wang
Pierre Renard
Bruno Pfeiffer
Beatrice Guardiola
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ADIR SARL
Original Assignee
ADIR SARL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ADIR SARL filed Critical ADIR SARL
Application granted granted Critical
Publication of DE69400692D1 publication Critical patent/DE69400692D1/de
Publication of DE69400692T2 publication Critical patent/DE69400692T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
DE69400692T 1993-07-23 1994-07-12 Substituierte Piperazine, ihre Verfahrensherstellung und die enthaltenen pharmazeutischen Zusammenfassungen Expired - Fee Related DE69400692T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9309088A FR2707984B1 (fr) 1993-07-23 1993-07-23 Nouvelles pipérazines substituées, leur procédé de préparation et les compositions les contenant.

Publications (2)

Publication Number Publication Date
DE69400692D1 DE69400692D1 (de) 1996-11-14
DE69400692T2 true DE69400692T2 (de) 1997-05-07

Family

ID=9449559

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69400692T Expired - Fee Related DE69400692T2 (de) 1993-07-23 1994-07-12 Substituierte Piperazine, ihre Verfahrensherstellung und die enthaltenen pharmazeutischen Zusammenfassungen

Country Status (14)

Country Link
US (2) US5492912A (de)
EP (1) EP0638568B1 (de)
JP (1) JPH0753548A (de)
AT (1) ATE143955T1 (de)
AU (1) AU674759B2 (de)
CA (1) CA2128560A1 (de)
DE (1) DE69400692T2 (de)
DK (1) DK0638568T3 (de)
ES (1) ES2095726T3 (de)
FR (1) FR2707984B1 (de)
GR (1) GR3021770T3 (de)
HK (1) HK56697A (de)
NZ (1) NZ264062A (de)
ZA (1) ZA945423B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5883098A (en) * 1993-11-29 1999-03-16 Fujisawa Pharmaceutical Co., Ltd. Piperazine derivatives
FR2757158B1 (fr) * 1996-12-18 1999-04-02 Lipha Nouveaux derives d'acide 4-(1-piperazinyl) benzoique, leur procede de preparation et leurs applications therapeutiques
FR2763334A1 (fr) * 1997-05-13 1998-11-20 Lipha Derives anthraniliques
PL372695A1 (en) 2002-06-19 2005-07-25 Solvay Pharmaceuticals Gmbh Medicament for the treatment of diseases requiring inhibition or a reduction in the activity of ph value-regulating bicarbonate transporter proteins
FR2846656B1 (fr) * 2002-11-05 2004-12-24 Servier Lab Nouveaux derives d'imidazopyridine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
IL280864B2 (en) 2013-08-09 2024-03-01 Ardelyx Inc Compounds and methods for inhibiting phosphate transport
JP7177495B2 (ja) * 2016-09-21 2022-11-24 ベクタス・バイオシステムズ・リミテッド 高血圧症及び／又は線維症を処置するための組成物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL72956C (de) * 1947-11-12
CH506548A (de) * 1966-08-10 1971-04-30 Serono Ist Farm Verfahren zur Herstellung von 2-aminsubstituiertem 4,5-Diphenyl-Oxazol
DE3752141T2 (de) * 1986-02-24 1998-03-26 Mitsui Petrochemical Ind Mittel zur behandlung von neuropathie
US5091428A (en) * 1987-04-24 1992-02-25 Syntex Pharmaceuticals, Ltd. Substituted imidazolyl-alkyl-piperazine and -diazepine derivatives
EP0324520A3 (de) * 1988-01-14 1990-08-16 Merck & Co. Inc. Alkyl-piperazinyl-5,6-alkylenpyrimidine

Also Published As

Publication number Publication date
HK56697A (en) 1997-05-09
FR2707984B1 (fr) 1995-09-01
JPH0753548A (ja) 1995-02-28
AU6860594A (en) 1995-02-02
ATE143955T1 (de) 1996-10-15
US5500426A (en) 1996-03-19
EP0638568B1 (de) 1996-10-09
ZA945423B (en) 1995-03-01
NZ264062A (en) 1995-04-27
AU674759B2 (en) 1997-01-09
DK0638568T3 (de) 1997-03-24
US5492912A (en) 1996-02-20
EP0638568A1 (de) 1995-02-15
GR3021770T3 (en) 1997-02-28
CA2128560A1 (fr) 1995-01-24
FR2707984A1 (fr) 1995-01-27
ES2095726T3 (es) 1997-02-16
DE69400692D1 (de) 1996-11-14

Similar Documents

Publication Publication Date Title
DE59407626D1 (de) Sulfonylaminopyrimidine, ihre Herstellung und Verwendung als Heilmittel
ATE45942T1 (de) Diarylacetylene, ihre herstellung und verwendung.
DE3772905D1 (de) Alpha-alkyl-4-amino-3-chinolin-methanole und 1-(4-aralkylamino-3-chinolyl)alkanone, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
DK0409435T3 (da) Heteroarylpiperaziner som antipsykotiske midler
DE59209965D1 (de) Chinoxaline, Verfahren zu ihrer Herstellung und ihre Verwendung
NO179834C (no) Substituerte cykloheksanderivater og anvendelse av forbindelsene for fremstilling av legemidler
DK0571253T3 (da) Benzimidazolderivater med antidiabetisk og antiblodpladekoagulerende virkning
DE69431316D1 (de) Amidderivate und ihre therapeutische Verwendung
DE69400692D1 (de) Substituierte Piperazine, ihre Verfahrensherstellung und die enthaltenen pharmazeutischen Zusammenfassungen
ATE66209T1 (de) Dihydropyridinamide, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln.
DE3673468D1 (de) N-alkyl-2,6-dimethylmorpholinio-carbonsaeureamid-salze, verfahren zu ihrer herstellung und ihre verwendung als fungizide.
AU648924B2 (en) New 1-(alkoxybenzyl)piperazine amide compounds, processes for preparing them and pharmaceutical compositions containing them
ATE131819T1 (de) 2-hydroxy-3-phenoxy-propyl-substituierte piperazine, ihre herstellung und verwendung
NO961168L (no) Nye uretanholdige aminosteroid forbindelser
ES2123728T3 (es) Derivados de pirrolo-pirazina de actividad 5-ht3.
DE69007196D1 (de) 2-Imino-3 heterocyclylamino-benzothiazoline, ihre Herstellung und sie enthaltende Arzneimittel.
ATE117896T1 (de) Arzneimittel welche substituierte 2-cyclohexen- 1yl-amin-derivate enthalten und ihre verwendung zur bekämpfung von krankheiten.
DE3262353D1 (en) N,n-disubstituted alkenamides and phenylalkenamides, processes for their production and their use as pharmaceuticals
ATE17485T1 (de) 3,7a-diazacyclohepta(j,k)fluorenderivate, ihre herstellung und ihre therapeutische verwendung.
ATE119394T1 (de) Verwendung von myricetin-3-0-beta-d-glucuronid als arzneimittel.
ATE158576T1 (de) Alpha-aryl-alpha-hydroxy-beta- imidazolinylpropionsäureamide
ATE108783T1 (de) 2-imino-6-polyfluoralkyl-3-heterocyclylalkyl- benzothiazolinderivate, ihre herstellung und sie enthaltende arzneimittel.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee